Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2008 pubmed 57 citations

The role of kisspeptin and GPR54 in the hippocampus.

Arai. Amy C AC

Key Findings

  • Kisspeptin‑10 activation of GPR54 sharply increases excitatory synaptic amplitude in dentate granule cells
  • The potentiation is postsynaptic, likely involving more or more conductive AMPA receptors
  • The effect requires ERK1/2, tyrosine kinase, and CaMKII signaling pathways
  • KiSS‑1 mRNA rises with neuronal activity and seizures, suggesting an activity‑dependent, autocrine role

Practical Outcomes

  • At present there’s no actionable protocol for using kisspeptin‑10 to enhance cognition or treat epilepsy. The findings point to the kisspeptin/GPR54 system as a potential drug target, but human studies, dosing, and safety data are still missing. Biohackers should treat this as interesting basic science rather than a ready‑to‑use supplement.

Summary

The study shows that kisspeptin‑10 can quickly boost the strength of excitatory signals in a specific part of the hippocampus, likely by increasing the number or activity of AMPA receptors on the receiving cells. This effect depends on internal cell signaling pathways (ERK, CaMKII, tyrosine kinases) and seems to happen naturally when neurons are highly active or during seizures. While it hints that kisspeptin might influence learning, memory, or seizure risk, the research is done in rat brain slices, not humans, and gives no guidance on dosing or safety for people.

Abstract

The granule cells of the dentate gyrus form the input stage of the hippocampal trisynaptic circuit and their function is strongly influenced by peptidergic systems. GPR54 is highly and discretely expressed in these cells. We have found that activation of GPR54 with kisspeptin-10 causes a rapid and large increase in the amplitude of excitatory synaptic responses in granule cells, without changing membrane properties. The effect was suppressed by the G-protein inhibitor GDP-beta-S and the calcium chelator BAPTA, and analysis of miniature EPSCs revealed an increase in mean amplitude but not event frequency, indicating that GPR54 and the mechanisms for enhancing EPSCs are postsynaptic, possibly involving changes in AMPA receptor number or conductance. The kisspeptin-induced synaptic potentiation was abolished by inhibitors of ERK1/2, tyrosine kinase, and CaMKII. RT-PCR experiments showed that KiSS-1 is expressed in the dentate gyrus. KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by kainate or picrotoxin, while mRNA for GPR54 remained essentially unchanged. These results suggest that kisspeptin may be locally synthesized and act as an autocrine factor. In separate experiments, hippocampal KiSS-1 mRNA in male rats was increased after gonadectomy. In summary, kisspeptin is a novel endogenous factor which is dynamically regulated by neuronal activity and which, in marked distinction from other neuropeptides, increases synaptic transmission in dentate granule cells through signaling cascades possibly linked to the MAP kinase system. This novel peptide system may play a role in cognition and in the pathogenesis of epilepsy.

Study Information

Provider

pubmed

Year

2008

Date

2008-08-13T00:00:00.000Z

DOI

10.1016/j.peptides.2008.07.023

Citations

57

References

99